George Thomas
10Patents
3h-index
26Co-inventors
60Inventor score
Filing activity: Jul 14, 1992 → Nov 26, 2013
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5342846A | 7-substituted-6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid compounds and 7-(substituted triazolyl pyrrolidin-1-yl) 4-oxoquinoline-3-carboxylic acid derivatives useful as antibacterial agents | Chemistry; Metallurgy | 37 | Expired |
| US6534311B2 | Drosophila melanogaster p70S6 kinase | Human Necessities | 9 | Expired |
| US6833255B1 | Drosophila melanogaster p70 S6 kinase | Human Necessities | 9 | Expired |
| US6635621B1 | Cysteine protease inhibitors | Human Necessities | 3 | Expired |
| US6916803B2 | 3-(Heteroaryl acetamido)-2-oxo-azetidine-1-sulfonic acids derivatives as antibacterial agents | Emerging Cross-Sectional Technologies | 2 | Expired |
| US7749698B2 | p53 wild-type as biomarker for the treatment with mTOR inhibitors in combination with a cytotoxic agent | Physics | 1 | Active |
| US9261498B2 | Biomarker for sensitivity to mTOR inhibitor therapy in kidney cancer | Physics | 0 | Active |
| US5994342A | 3-(substituted methyl)-4-oxa-1-azabicyclo[3.2.0]heptan-7-one derivatives useful as antitumor agents | Emerging Cross-Sectional Technologies | 0 | Expired |
| US5652234A | 3-(7-oxo-1-aza-4-oxabicyclo[3.2.0]hept-3-yl)alanine derivative as antitumor agent | Human Necessities | 0 | Expired |
| US9279811B2 | Methods and kits that identify tumors responsive to Src inhibitors | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.